Correlation Between Kindom Construction and Medigen Biotechnology

Can any of the company-specific risk be diversified away by investing in both Kindom Construction and Medigen Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kindom Construction and Medigen Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kindom Construction Corp and Medigen Biotechnology, you can compare the effects of market volatilities on Kindom Construction and Medigen Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kindom Construction with a short position of Medigen Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kindom Construction and Medigen Biotechnology.

Diversification Opportunities for Kindom Construction and Medigen Biotechnology

-0.67

Correlation Coefficient

Kindom Construction  Medigen Biotechnology

Excellent diversification

The 3 months correlation between Kindom and Medigen is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Kindom Construction Corp and Medigen Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Biotechnology and Kindom Construction is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kindom Construction Corp are associated (or correlated) with Medigen Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Biotechnology has no effect on the direction of Kindom Construction i.e., Kindom Construction and Medigen Biotechnology go up and down completely randomly.

Pair Corralation between Kindom Construction and Medigen Biotechnology

Assuming the 90 days trading horizon Kindom Construction Corp is expected to generate 0.87 times more return on investment than Medigen Biotechnology. However, Kindom Construction Corp is 1.14 times less risky than Medigen Biotechnology. It trades about 0.07 of its potential returns per unit of risk. Medigen Biotechnology is currently generating about 0.01 per unit of risk. If you would invest  2,749  in Kindom Construction Corp on September 20, 2024 and sell it today you would earn a total of  2,361  from holding Kindom Construction Corp or generate 85.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	99.79%
Values	Daily Returns

Kindom Construction Corp  vs.  Medigen Biotechnology

Kindom Construction Corp

Risk-Adjusted Performance

5 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Kindom Construction Corp are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Kindom Construction may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Medigen Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medigen Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Kindom Construction and Medigen Biotechnology

The main advantage of trading using opposite Kindom Construction and Medigen Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kindom Construction position performs unexpectedly, Medigen Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Biotechnology will offset losses from the drop in Medigen Biotechnology's long position.

The idea behind Kindom Construction Corp and Medigen Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.